At times of humanitarian crisis, getting vital supplies to the frontlines fast can make a life-saving difference. Sadly, each year millions of children can’t access critical commodities in time, as governments struggle to mobilize funds quickly enough to buy vaccines and other essential supplies when they are needed most.
To reach children when it matters, UNICEF has created an innovative revolving fund, the Vaccine Independence Initiative (VII), that provides countries with prefinancing flexibilities, allowing for the timely purchase of essential commodities for health, nutrition, water, sanitation and hygiene, and education.
For impact investors and philanthropists (private donors, foundations, corporations), the VII provides the chance to maximize the social impact of their capital, while wealth and portfolio managers or investment advisors, can diversify the investment portfolio of their clients with a unique asset class with minimal risks and high social impact.
The VII’s track record
As a revolving fund, UNICEF’s VII sees investors recover their capital after 5 years at a low-risk interest rate of 0%, but with the assurance of maximum humanitarian impact for children, as the funds are used 10 times during the 5-year investment period (typically 2 times per year).
The investor journey
As the world’s largest children’s organisation, the scale and the impact UNICEF can achieve for children by leveraging its infrastructure, economies of scale, expertise, and global reach is truly unique. In terms of vaccines alone, each year UNICEF procures an estimated 2 billion doses of vaccines and reaches approximately 45% of the world’s children under five, in over 100 countries.
Speak to us
If you’re an investor, wealth manager, or philanthropist interested in learning more about the VII and other ethical investing opportunities with UNICEF, please contact UNICEF Ireland’s Head of Philanthropy, Donna Marie O’Donovan at email@example.com
Add value to your inbox!
Sign up to keep up to date on what's going on around the world.